Hykes Andrew 4
4 · Inari Medical, Inc. · Filed Dec 20, 2024
Insider Transaction Report
Form 4
Hykes Andrew
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-20$55.65/sh−600$33,390→ 439,310 total - Sale
Common Stock
2024-12-20$55.20/sh−2,400$132,480→ 439,910 total
Holdings
- 1,550(indirect: By Children)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
- 1,550(indirect: By Children)
Common Stock
- 1,550(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $54.56 to $55.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $55.56 to $55.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.